Addiction Audio

Aug 08 2024 87 ep. 21 mins 24
Addiction Audio Podcast artwork

Welcome to the podcast from the journal Addiction hosted by Dr Rob Calder - the social media editor for Addiction - alongside Ben Scher, Chloe Burke and Dr Elle Wadsworth. The podcast includes interviews with Addiction authors about their work, details about publishing in the journal, and other topics of interest to the field of addiction. This podcast is for researchers, clinicians, students, people with lived experience, and anyone with an interest in the topic.
Hosted on Acast. See acast.com/privacy for more information.

  Science  Health & Fitness  Society & Culture
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Young people and disposable e-cigarettes with David Hammond

Aug 08 2024 22 mins  
In this episode Dr Elle Wadsworth talks to Professor David Hammond about vaping. They discuss policy differences between the Canada, the UK and the US as well as changes relating to disposable vapes and the use of nicotine salts. They cover the environmental impact of some of these products before talking about the different choices available to policymakers when developing regulat

Opioids, cancer and mortality with Aleksi Hamina

Jul 18 2024 13 mins  
In this episode Ben Scher talks to Dr Aleksi Hamina from the Norwegian centre for addiction research at the University of Oslo and the Niuvanniemi Hospital in Finland. They discuss a recent paper co-authored by Dr Hamina in which the team matched large national datasets to identify excess mortality among people who use drugs that can be attributed to cancers. They found increases i

Cannabis potency and psychotic experiences with Lindsey Hines

Jun 06 2024 25 mins  
In this episode, Dr Rob Calder talks to Dr Lindsey Hines about her study using longitudinal data to examine links between cannabis use, cannabis potency and psychotic experiences. Dr Hines talks about using Avon Longitudinal Study of Parents and Children (ALSPAC) data - also known as 'Children of the Nineties' and discusses why psychosis and cannabis potency are important to measur

Cannabis use in the US with Jonathan Caulkins

May 22 2024 22 mins  
In this episode Dr Elle Wadsworth talks to Professor Jonathan Caulkins about self-reported cannabis use in the US between 1979 and 2022 and how those trends compare with alcohol use over the same period. The research focused on four specific time points, measuring cannabis prevalence against US policy changes. Dr Wadsworth and Professor Caulkins then talk about differences between

Integrated care vans with Kathleen Page

May 09 2024 26 mins  
In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page discusses using a cluster randomised trial to compare outcomes in different neighbourhoods (those where the van did and didn't go) and to explore whether the van was effective at improving

Smoking and abdominal obesity with Germán Carrasquilla

May 02 2024 17 mins  
In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of fat and note the importance of the findings for people who struggle to quit smoking. Germán talks about using Mendelian randomisation to identify a causal association between smoking a

Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith

Apr 25 2024 23 mins  
In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They discuss the complexities of providing treatment for people who use, and are prescribed, opiates, opiate agonist medications and benzodiazepines. They talk about using a combination of med

Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson

Apr 17 2024 27 mins  
In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment settings. They also talk about how contingency management can be used for stimulant use disorders; an area where there are relatively few evidence-based treatments.the team goes on to discu

Xylazine, heroin and drug markets with Caroline Copeland

Apr 09 2024 20 mins  
In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entered the US drug market but has been increasingly identified in Europe and the UK, even being identified in vapes sold as containing tetrahydrocannabinol (THC). Caroline covers the harms

Synthetic opioid production in Europe with Paul Griffiths

Apr 04 2024 33 mins  
In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss organised crime and its impact on cocaine production, drug availability and the potential for drug contamination. They also cover fentanyl and the potential for a heroin drought resulting